Jul 3, 2025
Happy Independence Day
The Macular Degeneration Association would like to wish everyone a safe and excellent 4th of July. The offices will be closed on Friday in observance of the 4th…
Resources
Jun 30, 2025
36-month results from phase 1/2a clinical study of RG6501 released
Author(s): Kassi Filkins Key Takeaways RG6501 (OpRegen) cell therapy shows sustained visual acuity and retinal structure improvements in GA patients over 36 months. Extensive coverage of OpRegen therapy leads to…
Jun 30, 2025
Redefining retinal care: Ixo-vec gene therapy for nAMD enters phase 3
Author(s): Glenn Yiu, MD, PhD Fact checked by: Sheryl Stevenson Frequent intravitreal injections for neovascular age-related macular degeneration present a long-term treatment burden, highlighting the need for innovative, durable solutions…
Jun 23, 2025
Instant coffee can cause blindness, says report
Published in Food Science & Nutrition, the study examined a large genetic dataset of more than 5,00,000 people and used sophisticated genetic correlation and Mendelian randomisation to investigate the association…
Jun 19, 2025
ILYX-002 rapidly improves immune-mediated dry eye disease in phase 2 trial
By Justin Cooper Fact checked by Christine Klimanskis, ELS Key takeaways: Dry eye disease associated with systemic autoimmune or inflammatory conditions significantly improved with ILYX-002 after 15 days. ILYX-002 targets…
Jun 16, 2025
Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
Author(s): Christine Curcio, PhD, Sheryl Stevenson Conferences|International SPECTRALIS Symposium – and Beyond From basal laminar deposits to foveal centering, a new framework refines what clinicians see—and what they treat—in outer…
Jun 16, 2025
Cataract surgery may curb dementia, Alzheimer’s risk in those without anxiety, depression
By Justin Cooper Fact checked by Christine Klimanskis, ELS Key takeaways: Cataract surgery had a protective effect against overall dementia and Alzheimer’s, but not vascular dementia. There was no protection…
Jun 16, 2025
Undiagnosed AMD prevalence in urban setting higher than national average
By Alex Young Fact checked by Eamon N. Dreisbach Key takeaways: A hospital in New York had a higher percentage of undiagnosed AMD compared with CDC reported values. Researchers hope…
Jun 12, 2025
FDA nod for acoltremon: What its approval means for clinicians and patients
Author(s): Sheryl Stevenson Alcon’s announcement of the FDA approval for its acoltremon ophthalmic solution 0.003% (Tryptyr; formerly AR-15512) for the treatment of signs and symptoms of dry eye disease (DED)1,2 brings…
Jun 10, 2025
Press Release PAO Action Week
Press Release Hello, The Macular Degeneration Association is one of the 1,200+ patient advocacy organizations (PAOs) in the United States working to support patients and caregivers. However, many people…
Jun 10, 2025
Home OCT a ‘safety net’ for reducing treatment burden in wet AMD
ByAnthony DeFino Fact checked byChristine Klimanskis, ELS Key takeaways: Home OCT may help patients achieve extended dosing intervals through consistent fluid evaluation. Scans are reviewed by AI through a cloud-based…
Jun 2, 2025
Stop Smoking Now to Protect Your Vision, Experts Warn
Edited by Shrabasti Bhattacharya TOPLINE: Current smokers faced up to 12-fold higher risk for age-related macular degeneration, a threefold higher risk for primary open-angle glaucoma, and a fourfold higher risk…
May 27, 2025
Aldeyra Therapeutics hits primary end point in 1 of 2 phase 3 trials for reproxalap
Author(s): Emily Kaiser Maharjan Key Takeaways Aldeyra’s phase 3 trial of reproxalap showed statistical superiority in reducing ocular discomfort compared to the vehicle, supporting NDA resubmission. The unique chamber trial…
May 26, 2025
Remember and Honor Our Fallen Heroes
“Their sacrifice was the ultimate act of love for their country. May we always remember them.” — Unknown
May 16, 2025
PARTICIPATE IN A MARKET RESEARCH STUDY ON VISUAL IMPAIRMENTS
Exafield US, a healthcare market research company based in the USA, is conducting a study on visual impairments and would love to hear your opinions! We are seeking English-speaking individuals…
May 15, 2025
Living with GA: How patients in the US and Western Europe cope
Living with GA: How patients in the US and Western Europe cope Author(s): Lynda Charters Key Takeaways Geographic atrophy significantly impacts patients’ daily activities, independence, and mental health, necessitating coping…
May 15, 2025
The eSight GO
By: Jeffry Gerson, OD, FAAO- Medical Director for the Macular Degeneration Association When we were at our recent in-person seminar in Denver, we had the opportunity to have a representative…
May 15, 2025
Valeda® Light Delivery System: The First FDA-Approved Treatment for Dry AMD
By: Jeffry Gerson, OD, FAAO- Medical Director for the Macular Degeneration Association Photobiomodulation (PBM) is a new treatment that was recently approved (November 2024) by the United States Food &…
May 15, 2025
Your Gut and Your Eyes: How a Healthy Gut Microbiome Can Help Protect Your Vision
by Julie Poteet, OD, MS, CNS, FOWNS If you’re living with macular degeneration, you’ve likely heard about vitamins, antioxidants, and eating leafy greens to protect your eyes. But did you…
May 12, 2025
Q&A: Katherine Talcott, MD, on exploring a potential connection between autoimmune diseases and AMD
May 11, 2025, By Sydney M Crago Katherine Talcott, a retina specialist at Cole Eye Institute at the Cleveland Clinic, presented at the Retinal World Congress 2025 meeting. In her presentation…
May 11, 2025
Happy Mother’s Day
Wishing all the moms a wonderful day.
May 2, 2025
“The effect of a specific vitamin supplement containing L-methylfolate (Ocufolin forte) in patients with neovascular age-related macular degeneration”
By: Tatjana Josifova a,*, Katarzyna Konieczka b,c, Andreas Sch€otzau d, Josef Flammer b a Eye Clinic Orasis, Department for Medical and Surgical Retina, Reinach, Switzerland b Department of Ophthalmology, University…
Apr 22, 2025
A Young Man with the Heart of Gold- Running for Rita- Update
Running for Rita update Maxim finished the Half Marathon in 1 hour and 49 minutes. “Race day was amazing—such a…
Apr 22, 2025
Treating dry eye disease may reduce migraine severity
By: Moira Mahoney Fact checked by: Christine Klimanskis, ELS Key takeaways: Treatment with ocular lubricants reduced Headache Impact Test scores in adults with migraine and dry eye disease. No significant…
Apr 17, 2025
One Day Only- Matters of Vision! 2025 Denver-Aurora, CO
Matters of Vision! 2025 Denver-Aurora, CO. The Macular Degeneration Association will host a Free educational program on Saturday, May 10th. Registration required- Call (855) 962-2852 to reserve your seat(s)- Limited…
Apr 17, 2025
Vantage Biosciences doses first patient in phase 2 study of VX-01, oral therapy for nonproliferative diabetic retinopathy
Author(s): Martin David Harp Key Takeaways Vantage Biosciences has begun a phase 2 trial for VX-01, targeting moderate to severe NPDR without CI-DME. The study is double masked, randomized, placebo…
Apr 6, 2025
Long-Term Visual Outcomes of Patients With nAMD Treated With Anti-VEGF Therapy Lost to Follow-Up
This is interesting and important. The bottom line: If you are getting treated for wet AMD and stop going to follow-ups, you are proven not to do as well as…
Mar 31, 2025
The Aira App: On Demand Expert Assistance
With the Aira app, people with vision loss connect to vetted, live, expertly trained assistants. Using the camera on your smartphone, they walk you through whatever task you’re struggling to…
Mar 26, 2025
Researchers develop eye drops that slow progressive vision loss in mice
March 24, 2025 By Jordana Joy, Associate Editor Researchers developed eye drop formulations 17-mer and H105A, both containing a short peptide, to administer to mice in the form of a drop…
Mar 24, 2025
Beyond Food: The Mediterranean Diet as a Holistic Approach to AMD Management
Join Our FREE Webinar! Topic: Beyond Food: The Mediterranean Diet as a Holistic Approach to AMD Management When: March 26, 2025, at 12 PM EDT Duration: 1 hour Learn how…